SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

RaveDAO is a global community uniting music, technology, and purpose. Since their first sold-out event at Dubai 2024, they have expanded across Europe, the Middle East, North America, and Asia, hosting world-class experiences with over 100,000 total attendees and 3,000+ attendees for each event.  RaveDAO has worked with top-tier artists like Vintage Culture, Don Diablo, Chris Avantgarde, Lilly Palmer, MORTEN, Bassjackers, and GENESI and has support from Binance, OKX, Bitget, and Polygon. RaveDAO is redefining live entertainment in Web3 and has active partnerships with 1001Tracklists, AMF, and Warner Music.  Beyond the dance floor, RaveDAO channels energy and attention toward impact. In 2025 alone, proceeds from its events helped restore sight to 400+ cataract patients in Nepal and fund over 150 meditation programs across the U.S.

RaveDAO

RaveDAO is experiencing intense social media activity as traders debate whether it is poised for a massive short squeeze or a repetitive pump-and-dump cycle. Community members are closely monitoring volume patterns and whale activity while drawing comparisons to other high-volatility assets.

Churchill Capital Corp. XI is a blank check company. It was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Michael Stuart Klein on June 4, 2025 and is headquartered in New York, NY.

Churchill Capital Corp XI - Ordinary Shares - Class A

Churchill Capital Corp XI is attracting significant interest due to its pending merger with Agility Robotics, a move that has sparked intense debate over whether it represents a transformative investment or a classic SPAC pump-and-dump scheme. While proponents highlight the company's high-profile backing from heavyweights like Amazon and Nvidia, skeptics are questioning the lack of tangible industrial sales and the inherent risks associated with the post-merger valuation model.

Shiba Inu (SHIB) is a decentralized, community-led cryptocurrency ecosystem built on the Ethereum blockchain. Originally launched as a meme-based project, it has evolved into a comprehensive financial ecosystem designed to offer a decentralized alternative to traditional banking. Its main value proposition lies in its transition from a social phenomenon into a functional utility network, supported by a vast global community known as the ShibArmy and a commitment to 100% community ownership with no central leadership.  The ecosystem features its own decentralized exchange, ShibaSwap, where users can trade, provide liquidity, and earn rewards. To address Ethereum’s high costs and slow speeds, the project utilizes Shibarium, a Layer 2 scaling solution that processes transactions faster and more affordably.  The project employs a unique three-token model to manage its economy and governance. SHIB serves as the primary currency for trading and payments, while LEASH offers scarcity-based incentives for dedicated supporters. BONE acts as the governance token, allowing holders to vote on proposals through the Doggy DAO and serving as the native gas token for the Shibarium network.

Shiba Inu

Shiba Inu is facing significant community skepticism as investors express frustration over prolonged downward price action and compare the token unfavorably to emerging meme coins. Discussions are split between a disillusioned base predicting further decline and dedicated supporters maintaining long-term conviction while debating the impact of ecosystem developments.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain as well as the Onyx Goliath Blockchain. XCN is also used as an ERC-20 token for Staking and Governance.

Onyxcoin

Onyxcoin is seeing increased chatter as investors speculate on the upcoming Goliath mainnet launch and look for a breakout from long-term consolidation. While community sentiment is heavily polarized between long-term holders betting on institutional infrastructure utility and skeptics warning of a potential 'sell-the-news' event or liquidity scam, many are focused on technical support levels and volume spikes as key indicators of immediate momentum.

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Bristol-Myers Squibb Co.

Bristol-Myers Squibb is trending as investors react to positive clinical trial results for its cardiovascular drug Camzyos in adolescent patients and broader optimism surrounding its oncology pipeline, including the recent FDA priority review for iberdomide. Shareholders are also closely monitoring the company's defensive dividend appeal and recent pipeline collaborations, as the community debates whether these developments can effectively offset ongoing patent cliff pressures.

Bill Holdings, Inc. engages in the provision of cloud-based software solutions. The firm simplifies, digitizes, and automates complex back-office financial operations for small and midsize businesses. Its software helps customers generate and process invoices, streamline approvals, send and receive payments, sync with their accounting systems and manage their cash. The company was founded by Rene Lacertea in April 2006 and is headquartered in San Jose, CA.

BILL Holdings Inc

Bill.com Holdings Inc

Bill Holdings is under significant scrutiny as activist investors, including Starboard Value and Elliott Investment Management, push for a potential sale or strategic shift. Community sentiment remains polarized, with many investors frustrated by the stock's persistent decline while simultaneously speculating that a buyout at a premium is inevitable given the company's solid balance sheet and depressed valuation.

Oatly Group AB is a holding company, which focuses on developing expertise around oats, a global power crop with inherent properties suited for sustainability and human health. It operates through the following geographical segments: Europe & International, North America and Greater China. The company was founded by Björn Öste in 1994 and is headquartered in Malmö, Sweden.

Oatly Group AB - ADR

Oatly Group

Oatly is trending as investors monitor ongoing strategic reviews of its China operations and potential asset divestitures that could significantly impact the company's balance sheet and debt levels. The community is focused on the brand's pivot toward high-margin product innovation and increased shelf-space penetration, with many awaiting official updates on a China joint venture to act as a catalyst for a re-rating.

Polkadot is a platform that allows diverse blockchains to transfer messages, including value, in a trust-free fashion; sharing their unique features while pooling their security. In brief, Polkadot is a scalable heterogeneous multi-chain technology.  Polkadot is heterogeneous because it is entirely flexible and makes no assumption about the nature or structure of the chains in the network. Even non-blockchain systems or data structures can become parachains if they fulfill a set of criteria.  Polkadot may be considered equivalent to a set of independent chains (e.g. a set containing Ethereum, Ethereum Classic, Namecoin and Bitcoin) except with important additions: pooled security and trust-free interchain transactability.  Many of the native parachains of Polkadot will be written using a Polkadot Runtime Environment SDK (e.g. Parity Technologies' Substrate).

Polkadot

Polkadot is facing intense community debate as the token trends amid a shift in its tokenomics toward a capped supply model, fueling conflicting narratives between long-term holders betting on a structural recovery and skeptics pointing to recent price depreciation. While some investors are highlighting the potential for a rebound driven by network upgrades and institutional interest, many voices are expressing frustration over stagnant performance and questioning the asset's long-term utility in a competitive crypto landscape.

United Microelectronics Corp. is engaged in the semiconductor foundry company which provides IC fabrication services, focusing on logic and various technologies to serve all major sectors of the electronics industry. It offers complementary metal-oxide semiconductor logic wafers, mixed signal wafers, radio frequency complementary metal-oxide semiconductor wafers, embedded memory products, high voltage integrated circuits, and complementary metal-oxide semiconductor image sensors. The company was founded on May 22, 1980 and is headquartered in Hsinchu, Taiwan.

United Micro Electronics - ADR

United Microelectronics Corporation

United Microelectronics Corporation is drawing significant investor interest as it aggressively scales its specialty foundry capacity and advances a strategic partnership with Intel for 12nm manufacturing. The community is actively debating the company's long-term valuation potential and its role in the global AI infrastructure supply chain, with many highlighting its resilient balance sheet and potential for structural re-rating.

Grayscale Bitcoin Mini Trust ETF - Common units of fractional undivided beneficial interest

Grayscale Bitcoin Mini Trust ETF

The Grayscale Bitcoin Mini Trust is capturing investor attention as BTC trends near annual support levels, sparking intense debate over whether current market conditions signal a generational buying opportunity or a deeper correction. Market participants are actively discussing the potential for a massive short squeeze in correlated assets like MicroStrategy, while technical analysts highlight the significance of recent buy-side stop volume and institutional accumulation patterns.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Gainers

Adicet Bio (NASDAQ:ACET) stock moved upwards by 22.9% to $10.14 during Thursday's pre-market session. The market value of their outstanding shares is at $77.1 million.
Bio-Techne (NASDAQ:TECH) stock movedread more...

Are Medical Stocks Lagging  Adicet Bio (ACET) This Year?

Here is how Adicet Bio, Inc. (ACET) and Biodesix, Inc. (BDSX) have performed compared to their sector so far this year.

Wall Street Analysts Believe Adicet Bio (ACET) Could Rally 319.64%: Here's is How to Trade

The average of price targets set by Wall Street analysts indicates a potential upside of 319.6% in Adicet Bio (ACET). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Adicet Bio to Participate in Fireside Chat at Jefferies Global Healthcare Conference

Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced that...

Adicet Bio Reports First Quarter 2026 Financial Results and Provides Business Updates

Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today reported financial...

Johnson & Johnson Sells 341,693 Shares of Adicet Bio, Inc. $ACET

Johnson & Johnson lessened its stake in Adicet Bio, Inc. (NASDAQ:ACET - Free Report) by 93.8% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 22,779 shares of the company's stock after selling 341,693 shares during the quart...

Adicet Bio (ACET) Expected to Announce Quarterly Earnings on Tuesday

Adicet Bio (NASDAQ:ACET) will be releasing its Q1 2026 earnings before the market opens on Tuesday, May 5. (View Earnings Report at...

Adicet Bio, Inc. (NASDAQ:ACET) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Shares of Adicet Bio, Inc. (NASDAQ:ACET - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the eight brokerages that are currently covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, one has assigned a hold ra...

Adicet Bio (NASDAQ:ACET) Stock Passes Below Two Hundred Day Moving Average - Here's Why

Adicet Bio (NASDAQ:ACET) Stock Price Crosses Below 200-Day Moving Average - Time to Sell...

Ra Capital Management, L.P. Buys 74,751 Shares of Adicet Bio (NASDAQ:ACET) Stock

Adicet Bio, Inc. (NASDAQ:ACET - Get Free Report) major shareholder Ra Capital Management, L.P. purchased 74,751 shares of the business's stock in a transaction on Friday, February 20th. The shares were acquired at an average price of $7.27 per share, with a total value of $543,439.77. Following the...

Adicet Bio, Inc. is a clinical stage biotechnology company, which engages in discovering and developing allogeneic gamma delta T cell therapies for cancer. It also focuses on developing a pipeline of “off-the-shelf” gamma delta T cells. The company was founded by Aya Jakobovits in November 2014 and is headquartered in Boston, MA.

Adicet Bio Inc

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	-$2.18	--	--	N/A
Q1 '26	-$3.08	-$1.88	38.88%	BEAT
Q4 '25	-$2.92	-$2.94	-0.82%	MISSED
Q3 '25	-$0.29	-$4.64	-1500.24%	MISSED
Q2 '25	-$0.30	-$0.34	-11.89%	MISSED

Feed

News

Sentiment

Earnings

Fundamentals

Info

ACETAdicet Bio Inc

Upcoming Earnings: Q2 '26

Historical Earnings

Latest ACET News